Quote | Biosyent Inc. (TSXVC:RX:CC)
Last: | $9.15 |
---|---|
Change Percent: | -0.65% |
Open: | $9.19 |
Close: | $9.15 |
High: | $9.19 |
Low: | $9.15 |
Volume: | 1,602 |
Last Trade Date Time: | 05/06/2022 04:56:26 pm |
News | Biosyent Inc. (TSXVC:RX:CC)
MISSISSAUGA, Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX ® is the #1 recommended iron supplement brand in Canada, based on a national survey of Canadian pharmacists and physicians ( 1) ....
MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2024. Key highlights include: Return on Equity for FY 2024 was 21% as com...
Message Board Posts | Biosyent Inc. (TSXVC:RX:CC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Biosyent Inc. Company Name:
RX:CC Stock Symbol:
TSXVC Market:
-0.65% G/L:
$9.15 Last:
1,602 Volume:
$9.19 Open:
$9.15 Close:
Biosyent Inc. Website:
MISSISSAUGA, Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX ® is the #1 recommended iron supplement brand in Canada, based on a national survey of Canadian pharmacists and physicians ( 1) ....
MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2024. Key highlights include: Return on Equity for FY 2024 was 21% as com...
Sparta Capital Ltd. (SAY:CA) is expected to report for quarter end 2024-12-31 BioSyent Inc. (RX:CA) is expected to report $0.15 for Q4 2024 Headwater Exploration Inc. (HWX:CA) is expected to report $0.2 for Q4 2024 Enterprise Group Inc. (E:CA) is expected to report for Q4 2024 Den...